TLR agonists are even being considered as treatments against pneumonia, as TLR2/6 and TLR9 agonists have been effective at reducing mortality when paired with oseltamivir during influenza A infection in mice [34]. Here, TLR2 is linked to susceptibility to pneumonia measurement.